![2020 03 04 21 21 6197 Artificial Intelligence Ai Hand 400 20200304215813](https://img.auntminnieeurope.com/files/base/smg/all/image/2022/06/ame.2020_03_04_21_21_6197_artificial_intelligence_AI_hand_400_20200304215813.png?auto=format%2Ccompress&q=70&w=400)
Private equity investor Apposite Capital has made an additional investment in cancer imaging software company Mirada Medical, bringing its total investment since 2019 to $20 million.
One of Mirada's software products in development is Simplicit90Y, which enables personalized dosimetry planning for TheraSphere, a radiation-based cancer treatment that uses microscopic radioactive glass microspheres.
Mirada's software is used in over 2,000 hospitals globally, Apposite said.